Morbidity and mortality following poliomyelitis – a lifelong follow‐up
ConclusionsPoliomyelitis has significant long‐term consequences on morbidity and mortality of both paralytic and non‐paralytic cases.
[ANGOP] Luanda -Luanda province will launch one more round of polio vaccination campaign on 13-15 December, announced the health officials.
[Dalsan Radio] The first phase of a nationwide integrated polio and measles vaccination campaign has concluded in Somalia having achieved high coverage.
Malaysia has begun a vaccination campaign in a rural town on Borneo island after a 3-month-old boy was confirmed to have polio in the country's first case of the highly infectious virus in 27 years
[Premium Times] The Africa Regional Certification Commission (ARCC) for poliomyelitis eradication will on Monday begin to assess if Nigeria has successfully eradicated wild poliovirus.
A three-month-old Malaysian infant has been diagnosed with polio, the first case reported in the country in nearly three decades, a top health official said on Sunday.
[Premium Times] Polio experts have said if Nigeria sustains its current trend of not detecting or reporting any new case of wild polio virus, Nigeria and Africa at large should be certified polio free before the end of 2020.
[The Conversation Africa] Great strides have been made in the global effort to eradicate polio. Reported cases of wild poliovirus have decreased by over 99% from an estimated 350,000 cases in 1988 to 33 in 2018.
[Vanguard] Dr. Pascal Mkanda, Coordinator, Polio Eradication Programme, at World Health Organisation (WHO), Africa Regional Office, has commended the Nigerian Government over its achievements in the area of Polio eradication.
CONCLUSIONS: IPV-OPV compared to OPV may reduce VAPPs without affecting vaccination coverage, safety or humoral response, except P2 with sequential schemes without P2 components, but increase poliovirus faecal excretion after OPV challenge for some polio serotypes. Compared to IPV-only schedules, IPV-OPV may have little or no difference on SAEs, probably has little or no effect on persons with protective humoral response, may increase neutralising antibodies, and probably reduces faecal excretion after OPV challenge of certain polio serotypes. Using three IPV doses as part of a IPV-OPV schedule does not appear to be better...
This article provides information on these and other travel vaccinations against hepatitis A, typhoid fever, rabies, Japanese encephalitis and cholera.Yellow fever endemic areas are located in Africa and in South America; there is no yellow fever in Asia. The meningococcal vaccine (A, C, W, Y) is required for pilgrims to Saudi Arabia. Additionally, it is recommended for travellers visiting the African "meningitis belt" during the dry season. A polio booster is required for countries with endemic wild-type polio virus (WPV) or circulating vaccine derived poliovirus (cVDPV).Hepatitis A is a common vaccine-prev...